After a year-long litigation battle, Wuxi NEST Biotechnology Co.,Ltd, has emerged victoriously in a patent infringement case filed by Copan Italia S.p.A. and Copan Industries, Inc. (“Copan”). The complaint alleged that NEST and some other swab manufactures and sellers violated section 337 of the Tariff Act of 1930 in the importation into the United States and sale of certain flocked swabs, kits containing flocked swabs, and methods of using same that infringe patents asserted. Copan requested that the USITC issue a general exclusion order, or in the alternative a limited exclusion order, and cease and desist orders.
Recently, the blogger “Wangcuncun” goes viral in China for nurturing a world of fluorescent “sea” by himself. He occupied himself in this business for the whole 2 weeks, plodding on the beach of South China Sea in search of fluorescent dinoflagellate in a length of 0.4mm. Through earnest attenuation and culture, the dinoflagellate successfully grew into a vast expanse of spectacular fluorescent “sea”.
NEST Product is adopted by WHO, Uganda in the clinic trial on three candidate Ebola Vaccines, which is launched by the World Health Organization collaborating with the government of Uganda. As is revealed by WHO, the first doses of the three candidates vaccines against the Ebola Virus Sudan are expected to arrive in Uganda in the following week.
WHAT IS ENDOTOXIN
It is a special component of the cell wall of gram-negative bacteria— lipopolysaccharide (LPS), which is released in large quantities after bacterial death and disintegration. When there is a sufficient amount of it in the body, a string of symptoms may occur, for instance, fever, microcirculation disturbance, endotoxin shock and disseminated intravascular coagulation, multiple organ failure, and sometimes death.
As a dedicated designer and manufacter of biotech products, NEST has assisted plenties of academics and researchers in achieving distinct accomplishment. The following is the journal article accomplished by the Research Team led by Prof. Zhang Yuyang, which is included in the academic journal Acta Pharmacologica Sinica. In this article, the structure basis of the feline drug GC376, an effective inhibition of SARS-CoV-2 is demonstrated.